What is it about?

Phenolic pyrazole derivatives were obtained in high yields, starting from esters of medically relevant phenolic acids and structures of all obtained compounds were determined by NMR and IR spectroscopy, and UV-Vis spectrophotometry. In addition, the single-crystal X-ray diffraction was used. Pyrazole derivatives were tested for their in vitro antioxidative (DPPH assay), and lipoxygenase (LOX) inhibitory activities. Radical quenching mechanism was estimated using DFT and thermodynamic approach, while molecular docking was used to estimate the binding mode within the enzyme. In this research, protocatechuic and vanillic acid pyrazole derivatives have been obtained for the first time. In vitro antioxidative assay suggests that pyrazole derivative of protocatechuic acid is a powerful radical scavenger, while anti-LOX assay indicates a pyrazole derivative with 4-hydroxyphenyl moiety.

Featured Image

Read the Original

This page is a summary of: Pyrazole derivatives of medically relevant phenolic acids: insight into antioxidative and anti-LOX activity, Medicinal Chemistry, June 2020, Bentham Science Publishers,
DOI: 10.2174/1573406416666200602152643.
You can read the full text:

Read

Contributors

The following have contributed to this page